City
Bay Area
471 announced deals involving Bay Area, most recent first, with the firms that advised on each.
Most recent
SEARCH ALL 471 Latham & Watkins Advises Pelthos Therapeutics in Combination With Castle Creek Biosciences 3 Nov 2026
Latham & Watkins Advises DoorDash on US$17 Billion Acquisition of Instacart 3 Nov 2026
Latham Advises CoStar Group in US$730 Million Acquisition of Vexcel 28 Oct 2026
Latham Advises Guidewire on Acquisition of hyperexponential 28 Oct 2026
Latham & Watkins Advises LSEG on US$3.535 Billion Acquisition of Octus 27 Oct 2026
Latham & Watkins Advises Arcus Biosciences on US$250 Million Public Offering of Common Stock 27 Oct 2026
Latham & Watkins Advises Morgan Stanley Capital Partners on Acquisition of The Rapid Group 21 Oct 2026
TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (Nasdaq: TCGX), a special purpose acquisition company (SPAC) sponsored by TCGX, have announced the execution of a definitive business combination agreement that will result in TriGemX Bio becoming a publicly traded company. The combined company will be named TriGemX Bio, Inc. and is expected to trade on Nasdaq under the new ticker symbol TGEM. Latham & Watkins LLP represents TCGX in the transaction with a corporate team led by Houston partners Ryan Maierson and Ryan Lynch, with associates Taylor Allison, Cooper Shear, and Luisa Gomez Yokubaitis, with assistance from Zachary Mouton. Advice was also provided on tax matters by Houston partner Jared Grimley, with associates Dominick Constantino and Graham Core; on benefits matters by Los Angeles partner Michelle Carpenter, with associate Jordan Barnes; on healthcare regulatory matters by Washington, D.C. partner Nathan Beaton and counsel Nicole Liffrig Molife and Chad Jennings, with associate Margaret Rote; on funds matters by Chicago partner David Moore and New York partner Jennifer Tian;* on data cybersecurity matters by New York partner Jessica Cohen, with associates Laura Geraci and Nat Lewis; on data privacy and cybersecurity matters by Bay Area partner Heather Deixler, with associate Ryleigh Chen; on environmental matters by Los Angeles/Houston partner Joshua Marnitz, with associate Brandon Kerns; on anti-bribery and anti-money laundering matters by Washington, D.C. partner Daniel Dominguez, with associates Patricia Amselem Bensadon and Ai Ni Lim; on antitrust matters by Washington, D.C. partner Jason Cruise and Washington, D.C. counsel Ngoc Hulbig; and on economic sanctions and export controls matters by Washington, D.C. partner Eric Volkman, with associate Amulya Vadapalli. *Admitted to practice in Illinois only. 21 Oct 2026
Latham & Watkins Advises Zocdoc on Acquisition of Sohar Health 19 Oct 2026
Latham & Watkins Advises AMD in Stability AI’s US$76 Million Fundraise 19 Oct 2026
Latham Advises on Vaxcyte’s Concurrent Public Offerings of Common Stock, Pre-Funded Warrants, and Convertible Senior Notes 8 Oct 2026
Latham & Watkins Advises Spectrum Equity on Growth Investment in Symmetric Health Solutions 7 Oct 2026
Latham & Watkins Advises Charlesbank in Completed Merger of Spectrotel and AireSpring 6 Oct 2026
Latham & Watkins Advises Tactacam on Completed Acquisition by GTCR 1 Oct 2026
Latham & Watkins Advises Long Lake in Completed US$6.3 Billion Acquisition of American Express Global Business Travel September 30, 2 1 Oct 2026
Latham & Watkins Advises AMD on US$8.2 Billion Acquisition of World Labs 30 Sept 2026
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering 28 Sept 2026
Latham & Watkins Advises Life Science Intelligence on Strategic Partnership With Opus Origin 25 Sept 2026
Latham & Watkins Advises on Vaderis Therapeutics’ US$152 Million Series B Financing 24 Sept 2026
Latham & Watkins Advises on Electra Therapeutics’ Upsized US$350 Million Initial Public Offering 21 Sept 2026
Latham & Watkins Advises American Real Estate Partners in Acquisition of a Minority Interest by Brookfield 17 Sept 2026
Latham & Watkins Advises Wonder on Its Strategic Partnership With DoorDash 17 Sept 2026
Latham & Watkins Advises Sequence AI Holdings in US$7.7 Billion Take-Private Acquisition of The Baldwin Group 17 Sept 2026
Latham Advises General Catalyst and a16z on Mistral AI’s €3 Billion Series D Funding Round 17 Sept 2026
Latham & Watkins Advises Carrick Capital Partners on Oversubscribed Continuation Vehicle and Commitment of US$255 Million New Capital to Saviynt 3 Sept 2026
Latham & Watkins Advises AMD in River AI’s US$1.1 Billion Funding 28 Aug 2026
Latham & Watkins Advises CaTECH in Acquisition of Envision Technology Group 28 Aug 2026
Latham & Watkins Advises Veritas Capital on US$1.1 Billion Sale of Epiq Solutions to TTM Technologies 19 Aug 2026
Latham & Watkins Advises AMD in US$4.75 Billion Senior Notes Offering 15 Aug 2026
Latham Advises Medical Faculty Associates in Transaction With the George Washington University and Universal Health Services 11 Aug 2026
Latham & Watkins Advises Bowman Consulting Group in US$1 Billion Acquisition by Bernhard Capital Partners 11 Aug 2026
Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO 10 Aug 2026
Latham & Watkins Advises Sequoia Capital on Valar Atomics’ US$1 Billion Series B Financing 6 Aug 2026
Latham & Watkins Advises WestView Capital Partners in Sale of Unified Patents to Anaqua 6 Aug 2026
Latham & Watkins Advises Silver Lake in Completed US$55 Billion Acquisition of Electronic Arts 5 Aug 2026
Latham & Watkins Advises Permira on US$2.4 Billion Sale of BioCatch to Visa 4 Aug 2026
Latham & Watkins Advises CordenPharma on Acquisition of AmbioPharm 4 Aug 2026
Latham & Watkins Advises on Reformation’s US$210.9 Million IPO 31 Jul 2026
Latham & Watkins Advises Nscale on Acquisition of Anyscale 31 Jul 2026
Latham Advises on Scribe Therapeutics’ US$155.51 Million IPO 28 Jul 2026
Latham Advises Crusoe on Partnership With ON.energy to Power AI infrastructure 24 Jul 2026
Latham Advises on Completed US$40 Billion Sale of Aligned Data Centers by Macquarie Asset Management 22 Jul 2026
Latham & Watkins Advises TYLsemi on US$43 Million Financing 15 Jul 2026
Latham Advises on Alto Neuroscience’s US$100 Million Underwritten Registered Direct Offering of Common Stock 14 Jul 2026
Latham & Watkins Advises SK Capital Partners on Sale of Milestone Environmental to I Squared Capital 8 Jul 2026
Latham & Watkins Advises Together AI in US$800 Million Series C 8 Jul 2026
Latham & Watkins Advises Reap Technologies in Completed Acquisition by Payward 2 Jul 2026
Latham & Watkins Advises Meta on Investment in CRED 1 Jul 2026
Latham & Watkins Advises Revmatics on Acquisition of DataFeedWatch 30 Jun 2026
Latham & Watkins Advises Sony Pictures Entertainment in US$100 Million Strategic Investment in Cosm 30 Jun 2026
Latham & Watkins Advises Vibe.co in Acquisition by Walmart 25 Jun 2026
Latham & Watkins Advises AMD on Acquisition of MEXT 17 Jun 2026
Latham & Watkins Advises Hybar in US$400 Million Senior Secured Green Notes Offering 17 Jun 2026
Latham & Watkins Advises Comoto on Investment by Gemspring Capital 16 Jun 2026
Latham & Watkins Advises on Digital Asset’s US$355 Million Funding Round to Accelerate Canton’s Role as Onchain Infrastructure for Capital Markets 16 Jun 2026
Latham Advises Warburg Pincus on Tender Offer for J.S.B. 16 Jun 2026
Latham & Watkins Advises on US$7 Billion Equity and Equity‑Linked Financing Transactions for Supermicro 12 Jun 2026
Lights Entertainment in Sale of US Showcase Cinemas Portfolio to Kinepolis 12 Jun 2026
Latham & Watkins Advises on Shattuck Labs’ US$75 Million Public Offering 11 Jun 2026
Latham & Watkins Advises on Hark’s US$700 Million Series A at US$6 Billion Valuation 11 Jun 2026